Israel's PlantArcBio wins US, South Korea patents for crop gene-editing platform

ANI

Updated At : 07:45 PM Sep 18, 2025 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Tel Aviv [Israel], September 18 (ANI/TPS): Israeli ag-biotech firm PlantArcBio announced Thursday that it has secured patents in the United States and South Korea for its DIPPER platform, which optimises gene-editing processes in crops.

The Tel Aviv-based company said the technology enhances the precision and efficiency of tools like CRISPR, accelerating the development of traits such as drought tolerance, yield improvement, and herbicide resistance.

CEO Dror Shalitin called DIPPER a "game-changing platform" that can shorten commercialisation timelines and boost global food security. (ANI/TPS)

(This content is sourced from a syndicated feed and is published as received. The Tribune assumes no responsibility or liability for its accuracy, completeness, or content.)

Tags :

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles